Sarah Holloway Poole, MSW, LCSWA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 14072 Elkin Highway 268, Ronda, NC 28670 Phone: 336-827-0089 |
News Archive
ExonHit Therapeutics today announced the signing of an exclusive agreement with Genmab A/S for a selection of novel splice variants, identified as part of a successful pilot study, that have the potential to be therapeutic targets for breast cancer. Genmab retains exclusive development and commercialization rights on 10 events out of a breast cancer database developed using ExonHit's genome-wide SpliceArray technology (RNA splicing analysis platform covering the entire genome).
"In an exclusive interview with Newsweek," Melinda Gates, co-chair of the Bill & Melinda Gates Foundation, discussed how "she has decided to make family planning her signature issue and primary public health a priority."
Patients who were treated for breast cancer or lymphoma are more than three times at risk for developing congestive heart failure, compared with patients who did not have cancer. Congestive heart failure is when the heart muscle does not pump blood as well as it should.
An international team of researchers including Zissis C. Chroneos, associate professor of pediatrics, and microbiology and immunology at Penn State College of Medicine, reveals how immune cells called macrophages activate to kill parasitic worms.
Researchers have found that an investigational treatment combination of a therapeutic vaccine and an immune-stimulator improves virologic control and delays viral rebound following the discontinuation of antiretroviral therapy (ART) in non-human primates infected with SIV, the simian form of HIV.
› Verified 4 days ago